Publications
5674 Results
- Journal / Conference
- Journal of Clinical Pathology 67(9):777-780;
- Year
- 2014
- Research Committee(s)
- Breast
- PMID
- PMID24989024
- PMC
- PMC4145412
- Study Number(s)
- CTSU/R9804
Web based pathology assessment in RTOG 98-04
- Journal / Conference
- British Journal of Haematology 166(3):352-359
- Year
- 2014
- Research Committee(s)
- Leukemia
- PMID
- PMID24712482
- PMC
- PMC4299460
- Study Number(s)
- E1905
Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine-treated patients with myelodysplastic syndromes
- Journal / Conference
- British Journal of Haematology 167(1):62-68;
- Year
- 2014
- Research Committee(s)
- Leukemia
- PMID
- PMID24995683
- PMC
- PMC4299466
- Study Number(s)
- E1905
Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS
- Journal / Conference
- Pharmacogenomics Journal 214(5):424-431;
- Year
- 2014
- Research Committee(s)
- Lung
- PMID
- PMID24709690
- PMC
- pending
- Study Number(s)
- S0124
The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis
- Journal / Conference
- AACR Research International Conference on Frontiers on Cancer Research Prevention (Sept 28-Oct 1, 2014, New Orleans, LA; poster
- Year
- 2014
- Research Committee(s)
- Breast, Gastrointestinal, Genitourinary, Gynecologic, Leukemia, Lung, Lymphoma, and Sarcoma
- Study Number(s)
- S0003, S0033, S0221, SWOG-8507, SWOG-8516 (INT-0067), SWOG-8600, SWOG-8706, SWOG-8736 (INT-0093), SWOG-8795 (INT-0094) (EST-1888), SWOG-8814, SWOG-8897, SWOG-8949, SWOG-9012, SWOG-9031, SWOG-9308, SWOG-9333, SWOG-9346, SWOG-9420, SWOG-9500, SWOG-9509, S9701, S9916
Association between BMI at treatment initiation and cancer survival across multiple SWOG trials
- Journal / Conference
- San Antonio Breast Cancer Symposium, abstr. [P3-11-16]; poster presentation;
- Year
- 2014
- Research Committee(s)
- Breast
- Study Number(s)
- S0800
S0800: Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim with or without Bevacizumab in Treating Women with Inflammatory or Locally Advanced Breast Cancer (NCI CDR0000636131)
- Journal / Conference
- Nature Genetics 46(12):1356-1362;
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID25383972
- PMC
- PMC4244251
- Study Number(s)
- S0000
Leveraging population admixture to explain missing heritability of complex traits
- Journal / Conference
- Blood 124(21):LBA-5; American Society for Hematology (December 6-9, 2014, San Francisco, CA), LBA, oral;
- Year
- 2014
- Research Committee(s)
- Leukemia
- Study Number(s)
- S1117
A randomized phase II study of azacitidine combined with lenalidomide or with vorinostat vs. azacitidine monotherapy in higher-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML): North American Intergroup study SWOG S1117
- Journal / Conference
- San Antonio Breast Cancer Symposium Annual Meeting (December 9-13, 2014, San Antonio, TX),abstr. [S3-08], oral presentation;
- Year
- 2014
- Research Committee(s)
- Breast
Randomized comparison of adjuvant tamoxifen (T) plus ovarian function suppression (OFS) versus tamoxifen in premenopausal women with hormone receptor-positive (HR+) early breast cancer (BC): analysis of the SOFT trial
- Journal / Conference
- Nature Genetics 46(10):1103-1109;
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID25217961
- PMC
- PMC4383163
- Study Number(s)
- S0000